Introduction
It has been reported (1) that one effect of a single, intra-peritoneal dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin) is to cause a reduction in the duration of action of the drug 2-amino-5-chlorobenzoxazole (zoxazolamine) in the rat. This effect is maximal with doses of dioxin above 100J,g/ kg and significant even at 5 jug/kg. Our own work showed that oral dosage had a similar effect but also that the duration of action of hexobarbitone was consY(1erably prolonged (2) . The results describc-d here extend these observations.
Materials and Methods

Animals
Rats of the albino Porton strain bred in these Laboratories and weighing 180-200 g (male [6] [7] [8] weeks and female 7-10 weeks old) had free access to water and diet 41B unless otherwise indicated.
Mice of the C57BL/6 and DBA/2 strains were bred in these laboratories and kept on Sterolit bedding (Mineral & Chemical Corporation of America, Menlo Park, New Jersey, U.S.A.) for at least 3 weeks before use. They had free access to diet and water. 
Dosages
Dioxin, prepared as described elsewhere (3), was administered as a solution (100 ug/ ml) in Arachis oil. Control animals received an equivalent volume of oil. Zoxazolamine (McNeil Laboratories, Inc.) was dissolved in 1N HCI (1.2 ml/100 mg), diluted with 0.9%o NaCl to 10 mg/ml and administered IP at 100 mg/kg. 5-Cyclo-hex-1'-enyl-1,5-dimethylbarbituric acid (hexobarbitone) sodium (May & Baker Ltd.) was dissolved in water at 50 or 25 mg/ml and administered IP at 150 mg/kg (male rats), 75 mg/kg (female rats), 100 mg/kg (male and female mice). dl-Ethionine (Koch-Light) was dissolved in water (20 mg/ml) and administered as indicated in the text.
Microsomal Preparations
Liver microsomes were isolated either as described by Bond and De Matteis (4), except that the microsomes were sedimented at 105,000g, or by the calcium/sucrose method (5) adapted to the extent of sedimenting the calcium-treated microsomes at 1900g and washing them once in a 0.0125M sucrose solution containing 8mM CaC12. The final preparations were suspended in 0.1M phosphate buffer (pH 7.4) containing lmM Na2-EDTA (1.4 -7.0 mg protein/ml). Protein was estimated by the biuret method (6) and cytochrome P-450 (or P-448) by using an extinction coefficient of 91/mM-cm (7) for the absorbancy change between 450 (448) and 490 nm of the CO difference spectrum of a Na2S204-reduced suspension.
Assays Plasma barbiturate levels following hexobarbitone administration were measured by the method of Chromy and Babjuk (8) .
Hexobarbitone oxidase was measured in vitro by the modified (9) method of Brodie et al. (10) .
Zoxazolamine hydroxylase was measured by the methods of Burns and his colleagues (11, 12) ter) to the sample cuvet and of an equal volume of the appropriate solvent to the reference cuvet. Pyridine difference spectra were recorded with Na2S2O4-reduced microsomal suspensions (2.7 ml) and 0.3 ml of either 0.5M aqueous pyridine or water added to the cuvets. In view of the prolonged reduction of food intake of rats dosed with dioxin (3) it is possible that a starvation effect (13) It was considered possible that dioxin might prolong the hexobarbitone sleeping time by altering either the sensitivity of the nervous system or the distribution of the barbiturate within the body. These possibilities were ruled out by an experiment in which the sleeping times of groups of dioxintreated and control rats were measured and, immediately after their waking, blood was collected for the analysis of plasma barbiturate levels (8) . Table 2 indicates that, although there was a significant increase in the sleeping time of the dosed animals, the waking plasma barbiturate levels of the two groups were not significantly different. Three days after a single oral dose of either dioxin or oil to male or female rats the liver microsomes were isolated and incubated with an NADPH-generating system (20) . The relative intensity of these two peaks, related to the absorption at 500 nm, is dependent on the pH of the suspending medium (20) . In the case of liver microsomes prepared from animals pretreated with 20-mO-thylcholanthrene and therefore containing P-448 rather than P-450, the curve of pH dependence of the peak height ratio is so shifted that the peaks are of equal intensity at a lower pH (21) . The pH dependence of the pyridine difference spectra of microsomes from methylcholanthrene-, dioxin-or oil-treated rats was measured and is shown in Figure 1 . It can be seen that the curves due to dioxin or methylcholanthrene treatment are similar to each other but distinct from that of the control. 
Environmental Health Perspectives
It is known that, in the oxidized state, the cytochrome P-450 of liver microsomes will interact with various substrates of the drug metabolizing system to produce characteristic difference spectra (22) . We have studied the effect of dioxin pretreatment of rats on the interaction of aniline and hexobarbitone with rat liver microsomes. With aniline the control microsomes showed a normal Type II spectral change; this was intensified in the case of the microsomes from treated rats (Fig. 2) . Such a change is consistent with the increased cytochrome P-448 in these preparations. However, a double reciprocal plot of the spectral change/ nmole of P-450 (P-448) against aniline concentration indicated that there was an increase in Ks (binding affinity constant) and in the maximal Type II spectral change (Fig. 3) . A similar effect has been reported following methylcholanthrene induction (23 (7) was used in the estimation of cytochrome P-450 (-448). The spectral changes observed are related to the total cytochrome content of the cuvet.
The interaction of hexobarbitone with microsomes from control animals produced the expected Type I difference spectra (22) as illustrated in Figure 4 . However the microsomal preparations from rats which had received dioxin 3 days previously consistently gave a difference spectrum with a peak at 412 nm and a trough at 380 nm. This type of spectrum has been termed a modified Type II spectral change (22) and has been observed following methylcholanthrene pretreatment (24) , but only with microsomal preparations from female rats. A decrease in the intensity of the Type I difference spectrum due to hexobarbitone has been reported for methylcholanthrene-treated male and female rats (23) . Comparison of the Effects of 20-Methylcholanthrene and Dioxin on Zoxazolamine Action in Mice of the DBA/2 Strain All the changes of the properties of the liver microsomes from dioxin-treated rats are consistent with dioxin being a powerful inducer of the methylcholanthrene type. It has been reported that in mice of the DBA/2 strain the levels of hepatic aryl hydrocarbon hydroxylase are unaffected by methylcholanthrene (25) Table 5 ). 
Assuming that, under these conditions, the duration of zoxazolamine action is entirely governed by the rate of metabolism in the liver it would appear that the apparent genetic noninducibility of hepatic aryl hydrocarbon hydroxylase in certain mouse strains is not an absolute trait but dependent on the inducer used. This is in agreement with the observations (26) Although in the rat dioxin produces simultaneous and divergent effects on the metabolism of zoxazolamine and hexobarbitone by liver microsomes, it is not known whether these two effects are related to each other. An alternative would be that dioxin has two separate and distinct effects: the induction of zoxazolamine hydroxylase and the depression of hexobarbitone oxidase. The following two experiments indicate that, after dioxin treatment, a stimulation of zoxazolamine metabolism can be observed in the absence of any inhibition of hexobarbitone metabolism.
In mice of the C57BL/6 strain, as in the rat, a marked reduction of the zoxazolamine paralysis time was observed at 3 days after dioxin treatment. However, at this time the hexobarbitone sleeping time was either unchanged (in female mice) or shortened (in male mice); a prolongation was seen in males only at 20 days (Table 5 ). The effect of dioxin on hexobarbitone metabolism can also be suppressed in rats by administering dl-ethionine together with the dioxin. Along with a single oral dose of dioxin male rats were given a series of injections of dl-ethionine, an inhibitor of protein synthesis which has been reported as preventing the induction of drug metabolising enzymes by either 20-methylcholanthrene (27) or phenobarbitone (28) . It was found ( Table 6 ) that, whereas the ethionine was ineffective in preventing the reduction of paralysis time in dioxin-treated animals, it did abolish the prolongation of hexobarbitone sleeping time due to dioxin treatment. When the routes of administration of dioxin and ethionine were interchanged there was still no difference in hexobarbitone metabolism.
When the experiment was carried out with female rats, in which ethionine is a more effective inhibitor of protein synthesis (29) , the duration of both paralysis and sleep of the dioxin-treated animals was shorter than that of the controls (Table  6 ). Thus although these doses of ethionine are not effective in blocking the induced metabolism of zoxazolamine (27) in either sex, they are capable of preventing or even reversing the effect of dioxin on hexobarbitone metabolism.
Conclusions
1. The divergent effects of dioxin on the duration of action of hexobarbitone and zoxazolamine in the rat in vivo (2) are a consequence of changes in hepatic metabolism of these drugs.
2. Dioxin causes alterations in the properties of cytochrome P-450 of rat liver microsomes which are similar to those produced by methylcholanthrene.
3. It is the most effective stimulator of aromatic hydroxylation known, see (1) , and can apparently overcome a genetic resistance to hepatic microsomal enzyme induction in mice of the DBA/2 strain.
4. The effects of dioxin on hexobarbitone and zoxazolamine metabolism can be separated by the use of C57BL/6 mice or ethionine-treated rats and might be due to two separate modes of action.
